JUN 15, 2016 10:56 AM PDT

Bringing Macrophages Back From the Dark Side

WRITTEN BY: Kara Marker
When you think about how cancer cells continue to develop ways to grow and spread despite both the body’s and medicine’s best efforts, it’s almost as if they have a mind of their own. A new study from Ecole Polytechnique Federale De Lausanne (EPFL), a university in Switzerland, shows how a team of researchers are overcoming one of cancer’s mechanisms for metastasis to benefit a wide variety of people fighting cancer.
Immune cells (green) attacking tumor cells (red) 
 Macrophages are specialized immune cells descended from monocytes, and they destroy pathogenic and abnormal cells by engulfing them and breaking them into pieces. In some cases, cancer cells not only disable macrophages from engulfing other cancer cells, but they also turn around and recruit the body’s own macrophages to do their dirty work.
 
These “hijacked” immune cells are called tumor-associated macrophages (TAMs), and the research team from EPFL set out at the beginning of the study with the goal of bringing TAMs back from the dark side.
 
Natural, unaltered macrophages are modified by a small genetic molecule called microRNA (miRNA). In addition to warding off cancer cells, miRNAs guide macrophages to help repair the body during infection or other damage. When a macrophage is converted into a TAM, though, their miRNA control also changes to serve cancer-related purposes.
 
Previous studies showed that TAM miRNAs help the cancer cells stay hidden from the host immune system so they have time and resources to grow and spread to other body tissues. Whatever the reason for metastasis in any time of cancer, it’s an impending sign of a poor prognosis.
 
In attempt to resolve the issue, the researchers from EPFL genetically altered TAMs so they could no longer produce miRNAs. Without these molecular regulators, TAMs could not shield the growing tumor from the immune system, and the host was able to continue recognizing and attacking the cancer cells like normal. Even more, without miRNA to guide the TAMs, these hijacked macrophages actually released signals to the immune system, warning the host cells of a growing tumor.
 
The researchers identified a specific group of miRNAs that appeared to be causing the most trouble in TAMs: Let-7. While blocking the production of Let-7 miRNA successfully reversed the cancer-hiding effect, researchers are still unsure how to block Let-7 activity in TAMs and not in other macrophages, who still need miRNAs to function, that could be helping the immune system fight cancer.
 
The group from EPFL is currently working on this problem, though. Additionally, they discovered that blocking Let-7 in TAMs prevents further metastasis, which could improve prognoses for many cancer patients. Most excitingly, Michele De Palma, the team’s leader, says is that “TAM reprogramming greatly improved the efficacy of immunotherapy.”
 
With the impending ability to selectively block Let-7 in TAMs, De Palma and the team from EPFL could be on the verge on a brand new therapeutic strategy for boosting the immune system to fight cancer and prevent metastasis.
 
Their study was recently published in the journal Nature Cell Biology.
 

 
Sources:  Ecole Polytechnique Federale De Lausanne, Nature Reviews Immunology
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 24, 2018
Videos
JUL 24, 2018
Measles are on the Move
Measles is a highly contagious disease that used to be common in young children. Due to the development of vaccines, however, it’s been almost eradic...
JUL 31, 2018
Immunology
JUL 31, 2018
The Immune Systems Molecular Alphabet
Lab-designed nucleic acid nanoparticles elicit varied and specific immune response from immune cells based on shape, size, and formulation of each particle....
AUG 17, 2018
Health & Medicine
AUG 17, 2018
Is Influenza Different in Obese Patients?
There are many health risks for obese patients. Cardiovascular disease, diabetes and even some forms of cancer. The immune system can be disrupted when a p...
AUG 27, 2018
Immunology
AUG 27, 2018
Undiscovered Tunnels from Bone Marrow To Brain
Newly discovered tunnels connect bone marrow of the skull directly to lining of the brain to allow for quick access of immune cells to brain damaged tissues....
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
OCT 04, 2018
Videos
OCT 04, 2018
Why Do We Have Nightmares With a Fever?
Fever is the body’s response to a threat. When some viruses or bacteria try to enter the body, an immune response begins that can include a sharp ris...
Loading Comments...